Arrowhead Research | ARWR - EPS Earnings Per Share



Arrowhead Research reported $-1.26 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07 2025
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12 2025
FY2025Q1 Dec/2024 -1.39 -0.39 -1.24 Feb/10 2025
FY2024Q4 Sep/2024 -1.36 -0.97 -1.92 Nov/26 2024
FY2024Q3 Jun/2024 -1.38 -0.53 -0.96 Aug/08 2024
FY2024Q2 Mar/2024 -1.02 -0.47 0.45 May/09 2024
FY2024Q1 Dec/2023 -1.24 -0.80 -0.39 Feb/06 2024
FY2023Q4 Sep/2023 -1.92 -0.61 -0.81 Nov/29 2023
FY2023Q3 Jun/2023 -0.96 -0.73 -0.68 Aug/07 2023
FY2023Q2 Mar/2023 0.45 -0.68 0.41 May/02 2023
FY2023Q1 Dec/2022 -0.39 0.16 -0.6 Feb/06 2023
FY2022Q4 Sep/2022 -0.81 -0.29 -0.61 Nov/28 2022


Eps Change Date
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Arrowhead Research USD -1.26 4.01 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Ligand Pharmaceuticals USD 1.6 0.27 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
TG Therapeutics USD 0.17 0.14 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025
Xencor USD -0.41 0.25 Jun/2025